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Products of activated lymphocytes are known to  modulate the function of 
macrophages (1-3). Migration inhibitory factor (MIF) 1 is one of the best studied 
mediators of cellular immunity (4). Although many investigators have tried to 
analyze the biological and physicochemical properties of MIF from different 
species,  the  active  substance  has  not  been  purified  to  homogeneity.  MIF 
produced by guinea pig lymphocytes appears to be a glycoprotein with a mol wt 
of -  35,000-55,000  daltons  (5). Rocklin  et  al.  (6)  were able  to  differentiate 
highly purified guinea pig MIF from partially purified human MIF by using 
gel  filtration,  disc  electrophoresis,  isopycnic centrifugation,  and  enzymatic 
treatment.  They  determined MIF  activity  after  Sephadex  gel  filtration  in 
fractions containing molecules with a tool wt of -  23,000 daltons. 
The production of antibodies  to  guinea pig  and human lymphokines was 
demonstrated by Yoshida  et  al.  (7)  and  Bendtzen  (8), and  Geczy et  al.  (9) 
produced antibodies to partially purified guinea pig MIF, which inhibited the 
delayed skin reaction of sensitized guinea pigs challenged with purified protein 
derivative. These results prompted us to initiate immunochemical studies of 
the  mediators of cellular immunity in  man.  In  view of the  role of MIF  in 
cellular  immunity,  the  isolation  and  characterization of human  MIF  is  of 
paramount importance for the full evaluation of its role in different diseases, 
and for the development of rapid qualitative and quantitative methods for its 
detection. 
This paper describes the purification and immunochemical characterization 
of human MIF  produced by concanavalin A  (Con-A)-activated lymphocytes. 
The  specificity of anti-MIF  antibodies  is  demonstrated by  using  sensitive 
immunoelectrophoretic techniques.  MIF  activity  on  guinea  pig  peritoneal 
macrophages, as measured by the capillary test, is correlated with its effect on 
the electrophoretic mobility of macrophages. 
* Present address:  Department of Internal Medicine,  Section of Infectious Diseases,  Yale 
University School of Medicine, New Haven, Conn. 06510. 
Abbreviations used in this paper:  Con A, concanavalin A; EF, encephalogenic factor; MEM, 
Eagle's minimal essential medium; MIF, migration inhibitory factor; MSF, macrophage slowing 
factor; PBS, phosphate-buffered saline, pI, isoelectric  point; SDS, sodium dodecyl sulfate gel. 
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Materials and Methods 
Production of MIF-Rich Material by Human Lymphocytes.  Lymphocytes were isolated from 
human blood by centrifugation in Ficoll-Hypaque  gradients  (10).  After two washes  in  Hanks' 
buffer (Microbiological Associates, Bethesda, Md.) at room temperature, the cells were suspended 
in Eagle's minimal essential medium (MEM) containing 24 mM N-2-hydroxyethylpiperazine-N'- 
2-ethane sulfonic acid (Grand Island Biological Co., Grand Island, N. Y.), 100 U/ml of penicillin, 
and 100 ~I/ml of streptomycin  (Microbiological  Associates).  The viability  of the cells  was 
determined by trypan blue exclusion and was usually found to be ~  90%. The cells  at a 
concentration  of  107  cells/ml  (30-mi  volume) were then stimulated by  the addition  of  10 ~g of  Con 
A (Pharmacia Fine Chemicals Inc.,  Uppsala, Sweden) and incubated for  24  h at  37°C in  a 5% CO~ 
atmosphere in 250-mi plastic  tissue  flasks  (Falcon Plastics,  Div.  of  BioQuest, Oxnard, Calif.). 
After  centrifugation  at 18,000  g for  20 rain  at  4°C,  the supernates were dialyzed  against water at 
the same temperature for 24 h and then lyophilized.  The lyophilized  products of  40 x 500-mi 
lymphocyte supernates were each dissolved  in 5 ml of  0.01-M phosphate  buffer  (pH 7.4),  cleared 
by centrifugation  for  10  rain  at 10,000  g at  4°C,  dialyzed  against  the same buffer,  and applied  to a 
column packed with Sephadex G-100 (2.5 x  100 cm). The columns were precalibrated with 
albumin and chymotrypsinogen. Appropriate fractions  were pooled,  extensively  dialyzed  against 
water, lyophilised,  and tested for MIF activity.  For the capillary  test,  the dry, fractionated 
material was redissolved  in 2 ml of MEM  containing penicillin,  streptomycin, and 10% heat- 
inactivated  guinea pig serum; 50 or 100 ~l of  this  solution  was used.  Control supernates were 
prepared in the same way from cultures  to which Con A was added after  a 24-h incubation.  An 
equal amount  of the same material, prepared as described above, was tested in the cell 
electrophoresis  apparatus  according to  the methods of  Field  et  al. (11).  For  this  measurement, 50 
or 100 ~l of  MIF-rich material,  and equal amounts of  control  material were used. 
Preparative  Isotachophoresis.  Preparative  isotachophoresis  was  performed  according  to 
Svendsen and Rose  (12).  The lyophilized material obtained from 40  gel  filtration experiments 
was dialyzed against the cathode buffer (terminating electrolyte, 0.23 M e-aminocaproic acid and 
0.23 M Tris, pH 8.9) to which i ml of ampholine carrier ampholytes (pH 5-7 and 6-8, diluted 1:1, 40% 
wt/vol; LKB-Produkter AB, Bremma, Sweden) was added. The preparation was layered on top of 
the  polyacrylamide  gel  (3.3%)  in  an  LKB  7900  Uniphor,  equipped  with  an  LKB  7960  plastic 
column.  Trisphosphate  (0.03  M,  pH  6.25)  was  used  as  the  leading  electrolyte.  Fractions  were 
collected from the isotachophoresis column and they were  extensively dialyzed  (48 h)  against 
water.  Samples  of  50  or  100  pl  of  each  fraction  (6-ml  volumes)  were  tested  for  migration 
inhibitory activity and assayed in the cell electrophoresis apparatus. 
Chemical Analyses.  Protein  was  determined  by  the  method  of Lowry  et  al.  (13).  Bovine 
serum albumin was used as the standard. 
Analytical Polyacrylamide Gel Electrophoresis.  Analytical polyacrylamide gel electrophoresis 
was performed using the method of Ornsteirt (14) on 10% acrylamide gels in Tris-glycine buffer 
(pH 8.0). The gels were stained with Coomassie Brilliant Blue R 250. 
Polyacrylamide gel electrophoresis in 0.1% sodium dodecyl sulfate (SDS) was performed at pH 
7.2 in 10% acrylamide using the methods of Shapiro et al.  (15),  and Weber and Osborn (16).  The 
following proteins were used as  standards:  bovine serum  albumin  (tool wt 6.8  ×  104 daltens), 
rabbit-muscle phosphorylase  (tool wt  9.4  x  104 daltons)  and chymotrypsinogen  (mol wt  2.5  x 
104). To prevent proteolytic degradation, the samples were boiled for 3 rain in a  solution of 1% 
SDS and 1% 2-mercaptoethanol. The marker proteins were prepared in the same way. 
Isoelectric Focusing on Thin-Layer Polyacrylamide Gels.  The isolated protein was subjected 
to isoelectric focusing on 5% pelyacrylamide gel plate using the method of Awdeh et al.  (17). The 
samples and carrier ampholytes (pH 3-10) were set in the gel. The run was carried out for 16 h at 
4°C with a potential difference of 400 V between the two electrodes. After electrophoresis the gel 
was removed and fixed in 5% trichloracetic acid and stained with Coomassie blue. 
Preparation of Antisera.  The  antigens were dissolved at  a  concentration of 250  /~g/ml.  On 
days  0,  14,  28,  and 42,  two  rabbits weighing  2-2.5  kg  were  injected intracutaneously with  a 
standard mixture consisting of 50  ~1 antigen solution and 50 ~1 incomplete Fruend's adjuvant. 
On day 50, 45 ml of blood was drawn from an ear vein. Every 6th wk, 45 ml of blood was taken, 
the animals having received a  standard mixture of antigen 8-10 days before each bleeding. 
Isolation of  tmmunoglobulins and Purification by Affinity Chromatography.  25 g of (NH4hSO4 
was added to 100 ml of antiserum and the mixture was left at room temperature for about 20 h. BLOCK,  JAKSCHE,  BAMBERGER,  AND  RUHENSTROTH-BAUER  54~ 
Centrifugation at 4,000 g  for 30 min precipitated 98% of the antibody activity. The precipitate 
was washed once with -= 25 ml of 1.75 M  (NH4)~SO4 and the antibody-containing precipitate was 
transferred in a  small amount of water to a  25-ml dialysis bag. The suspension was dialyzed at 
4°C for 24 h  against two changes of distilled water,  for 24 h  against 0.021 M  acetate buffer (pH 
5.0), for 24 h  against two changes of distilled water,  and finally for 24 h  against acetate buffer 
(0.021  M,  pH  5.0).  The  supernate  was  transferred to  a  column  containing  24  ml  of DEAE- 
Sephadex  AS0  (Pharmacia Fine  Chemicals,  Uppsala,  Sweden)  and equilibrated with 0.021  M 
acetate buffer (pH 5.0). The IgG fraction was eluted with ---- 25 ml of acetate buffer. 
Affinity chromatography was used for further purification of the IgG fraction containing anti- 
MIF antibodies. Control material obtained from unstimulated cultures as described above was 
coupled to cyanogen bromide-activated Sepharose 2B (Pharmacia Fine Chemicals) according to 
the method of Porath (18).  Lyophilized supernates from 100 ml of unstimulated lymphocytes were 
dissolved in 5 ml of MEM, added to 5 ml of packed activated beads, and washed in 50 ml of 0.25 
M  sodium  bicarbonate  at  pH  9.  The  mixture  was  stirred  for  24  h  in  the  cold.  It  was  then 
transferred to a glass column and washed with 50 ml of phosphate-buffered saline (PBS), 50 ml of 
1  M  acetic  acid,  and  again  with  50  ml of PBS.  20  ml of the IgG fraction was  applied to  the 
column. The flow rate was 0.1 ml/min. The nonbound fraction was used for further investigations. 
Immunochemical  Techniques for Quantitation  of MIF Activity.  Antisera were analyzed using 
the method of Laurell (19). The concentration of the antiserum in the agarose gel was 4.5% (vol/ 
vol). The holes were filled with 5  ~l of antigen. After electrophoresis (10 V/cm for 2-3 h  or 2.5 
V/cm for 18 h), the gel was pressed. The filter paper was then gently removed and the plates were 
placed for 30 rain in 0.9% NaC1,  and for 30 rain in distilled water.  The gel was pressed again, 
dried,  and finally stained with Coomassie  Brilliant Blue.  Rocket  immunoelectrophoresis with 
intermediate gel was carried out according to Axelsen and Bock (20). 
Assay for MIF Activity.  The lyophilized MIF-rich material was dissolved in MEM medium 
containing penicillin, streptomycin,  and 10% inactivated guinea pig serum,  and it was assayed 
for MIF activity on guinea pig macrophages in capillary tubes.  Migration inhibition tests were 
performed according to the method of David and David  (21).  The chambers were  incubated at 
37°C  and the area of migration was drawn after 16 h  and measured by planimetry. The area of 
migration of four capillary tubes was  averaged and expressed as the percentage of migration 
according to the formula: 
MIF activity =  average area of MIF active preparation ×  100 
average area of control preparation 
Cell Electrophoresis.  The electrophoretic mobility of macrophages was determined according 
to  the  method  of Field  et  al.  (11)  by  suspending  l0  T cells  in  Medium  TC  199  (Grand  Island 
Biological Co., Grand Island, N. Y.) in a  2-ml volume. Macrophages were prepared as described 
by David  and David  (21)  and they were  incubated with the test material for 90 rain at room 
temperature.  The mobility was measured in the rectangular chamber of a  Zeiss cytophotometer 
(Carl Zeiss, Inc., New York) (22). 
Results 
Fractionation  and  Purification  of MIF-Rich  Material.  Fig.  1  shows  the 
elution pattern  of 500-ml  dialyzed and lyophilized supernates  of lymphocytes 
activated with Con A.  Most of the MIF activity was found in fractions  19-24. 
When  pooled,  dialyzed,  lyophilized,  and  tested  in  the  migration  inhibition 
assay, MIF activity was 40  ±  9.6% (15 determinations). 
Further enrichment of MIF activity was achieved by preparative isotachopho- 
resis.  Pooled fractions  from 40 gel filtration  experiments  (~  100  mg protein) 
were used (Fig. 2).  Most of the activity eluted in fractions 39-41 (B3) inhibited 
the  macrophage  migration  by 80  _+  8.5%  (6  determinations).  The  biological 
activity of fractions  42-44  (B2) was in the range  of 18  _+  10,5%  (4 determina- 
tions),  of fraction 45-47  (B1) in the range of 8  ±  5.8% (4 determinations),  and 
fraction  48-50  (A)  in  the  range  of 5.8  ±  5%  (4  determinations).  The  pooled 544  CHARACTERIZATION  OF  HUMAN  MIGRATION  INHIBITORY  FACTOR 
FzG.  1.  Activity  and  elution  profile  of  MIF-rich  supernates  on  Sephadex  G-100.  The 
material was eluted at a flow rate of =  32 ml/h, and 12 ml/tube were collected. Protein was 
measured by its absorbance at 280 nrn. For measurements for MIF activity, see Materials 
and  Methods and  text.  Analytical  polyacrylamide  gel  electrophoresis:  50  p]  of 250-fold 
concentrated  fractions  (15,  19,  24)  were  layered  on  each  gel.  Vertical  bars  represent 
standard deviation. Alb, albumin; Chy, chymotrypsinogen. 
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FIG.  2.  Biological  activity  and ultraviolet absorption at  280  nm  of the  effluent from a 
Uniphor column in which the MIF protein was separated by preparative isotachophoresis. 
Vertical bars represent standard deviation. 
material was extensively dialyzed, concentrated by vacuum dialysis to  1 ml, 
and  stored at  -70°C.  To  determine the purity of isolated  material after gel 
filtration,  analytical  polyacrylamide gel  electrophoresis  was  performed.  As 
shown in Fig. 1, gel electrophoresis on 10% polyacrylamide, pH 8.9,  of appropri- 
ate fractions (15, 19, 24) after gel filtration revealed multiple bands. 
A~er isotachophoresis, however, pool A (fractions 48-50)  showed one band on 
10%  acrylamide gel,  B1  (pooled  fractions  45-47)  showed  two  closely spaced 
bands,  B2  (pooled  from  fractions  42-44)  showed  one  diffuse  band,  and  B3 
(pooled from fractions 39-41)  showed one single diffuse band (Fig.  3).  On SDS 
gels (Fig. 4) pool A showed one dense band with an apparent tool wt of -  68,000 BLOCK, JAKSCHE,  BAMBERGER, AND  RUHENSTROTH-BAUER  545 
FIG.  3.  Polyacrylamide gel electrophoresis of purified material performed  after prepara- 
tive isotachophoresis.  10 ~1 of the concentrated material (1-ml vol) were placed  on each 
gel. A, pool of fraction 48-50; B1, pool of fraction 45-47; B2, pool of fraction 42-44; B3, pool 
of fraction 41-39. 
daltons  (protein  A).  The  pooled fractions  B1,  B2,  and  B3  seemed to  be con- 
taminated with small amounts of protein A. Pool B1 showed one band with an 
apparent mol wt of -  55,000 daltons, B2 contained the same band in addition to 
one other component of ~  28,000 daltons. B3 contained a major band with an ap- 
parept mol wt of ~  25,000 daltons but was contaminated with protein A and an 
additional  minor component with  a  mol wt of ~  34,000 daltons.  Since almost 
all  of the  migration  inhibition  activity  was  localized  in  B3,  it  was  assumed 
that this fraction contains MIF. 
The  isoelectric point  (pI)  of MIF protein  (B3) was found to be between 3.5 
and 4  (data not shown).  Although a  second minor band of faint intensity was 
observed in the same region, the MIF has a  purity of 90-95%. 
Yields of Purified MIF.  The  protein  content of 40 lymphocyte supernates 
(500-ml volume of each),  as estimated by Lowry et al.  (13),  was =1 g  (25 mg/ 
supernate; 5 determinations).  The MIF-rich material obtained and pooled after 
40  gel  filtration  experiments  contained  ~100  mg  protein  (2.5  mg  protein/ 
filtration; 5 determinations) or ---10% of the starting material. After preparative 
isotachophoresis,  fraction  A  yielded  ---1,950 ~g  (or  0.195%  of the  starting 
material),  fraction  B1  contained  750  ~g  (or 0.075%  of the  starting  material), 
fraction B2, 100 ~g (or 0.01% of the starting material),  and fraction B3 yielded 
250 ~g (or 0.025% of the starting  material). 546  CHARACTERIZATION  OF  HUMAN  MIGRATION  INHIBITORY  FACTOR 
FIG. 4.  Polyacrylamide gel electrophoresis  in SDS. 10 pl of  concentrated fractions  (1-ml 
vol)  A, B1, B2, and  B3 were loaded  onto the  gels  to  facilitate  the  comparison of  the  relative 
proportions  of  various contaminant proteins. 
The protein  content  of  the unfractionated  supernate which gave a migration 
inhibition of ~35-40%  was 0.4 mg/ml.  Using 1 ~g/ml of the purified MIF 
protein, ----45%  migration inhibition  was measured. Therefore, approximately 
400-fold  purification  in terms of  specific  MIF activity  per protein  content was 
achieved.  50 pl  of  the concentrated supernates (100-fold)  showed 40% inhibition 
of  migration. However, after  Sephadex G-100 filtration,  100 ~l of  the MIF-rich 
fraction  (concentrated  250-fold  in comparison with the starting  material)  also 
showed 35-45% inhibition.  This shows that although the specific  activity  of 
MIF-rich  material  was  considerably increased by  Sephadex  gel filtration, 
recovery of  MIF activity  was only about 20%. 
Immunoelectrophoresis.  The rocket  immunoelectrophoresis  technique was 
used according to the method of  Laurell (19).  Rabbit antisera  were produced 
against protein A  and against  the pool  of B1, B2, and purified  protein (B3) 
containing MIF activity.  Fig. 5 shows the immunoprecipitation  patterns ob- 
tained when  purified  proteins were run against anti-A antiserum.  Visible 
precipitation lines are  formed  with  pool A,  B1,  B2  (mixed), and  control 
supernates, but not against  protein  B3. The immunoelectrophoretic  pattern of 
antibodies  prepared against  the pool  of  B1, B2, and B3 is  demonstrated in Fig. 
6A. Precipitation  lines  appeared against the antigens B1, B2 (mixed),  B3, and 
the control  material.  Since anti-B  reacted  with all  the protein  fractions  tested BLOCK,  JAKSCHE,  BAMBERGER,  AND  RUHENSTROTH-BAUER  547 
FIG. 5.  Rocket immunoelectrophoresis of purified proteins and of nonstimulated control 
supernates, 5 ~tl of pools A, B1, B2, and B3 and control supornates were applied. Wells a, 
b, c, and d contained 0.5/~g/5  ~1 of substance A, 0.8 ~g/5/~1 of B1, B2 (mixed), 0.8/~g/5/~l 
of B3, and 0.8 ~g/5 pl of control supernate. The antibody solution was 4.5% immunoglobu- 
lins isolated from rabbit antiserum to substance A. Electrophoresis was performed at pH 
8.8 in a  buffer of 0.0245 M barbital, 0.073 Tris, 0.0003 M calcium lactate,  and 0.003 M 
sodium azide with 2.5 V/cm in the gel at 15°C for 18 h. The gel was stained with Coomassie 
Brilliant Blue R. The anode was at the top. 
and was not specific for fraction B3,  contaminating antibodies were present in 
this antiserum. To remove these contaminating antibodies, affinity chromatog- 
raphy was used. 
For this purpose, control supernates obtained from unstimulated lymphocytes 548  CHARACTERIZATION  OF  HUMAN  MIGRATION  INHIBITORY  FACTOR 
FIG. 6.  (A),  Rocket immunoelectrophoresis  of anti-MIF  antibodies before purification. 
The gel contained  4.5% immunoglobulins  obtained from rabbit  antiserum to pool  of  BI, 
B2, and B3. Antigens, 5 ~I/well  were: (a)  0.6 ~g/5 ~l of  control  I, (b) 1.5 pg/5 ~I of  control 
If, (c)  0.5 ~g/5/~l of  B3, (d)  0.8 ~g/5/~l of  B1, B2 (mixed), (e)  0.5/~g/5 ~l ofA. (B) Rocket 
immunoelectrophoresis  after  purification  of  anti-MIF antibodies.  The gel contained  4.5% 
immunoglobulins of  modified anti-MIF antibodies.  Purification  of  anti-MIF antibodies  was 
achieved by absorption of  anti-B by using affinity  chromatography.  Well (a)  0.6 ~g/5 pl of 
control  I, (b)  1.5  pg/5 ~l  of  control  II,  (c)  0.5 ~g/5 ~I  of  A, (d)  0.8 ~tg/5  ~l  of  B3, (e)  0.5 ~g/5 
~l of B1, (f) 0.5 ~g/5 ~l of B2. 
were bound to cyanogen bromide-activated  agarose  and  the  immunoglobulin 
fraction of anti-B was absorbed with this material. Fig. 6B shows the specificity 
of the absorbed anti-B.  A precipitation line is found only with fraction B3 and 
not with the other protein fractions tested. 
Biological Activity of MIF.  It was speculated by Preece and Light (23) that 
macrophage  slowing  factor  (MSF)  produced  by  sensitized  lymphocytes  after 
incubation with the encephalogenic factor (EF) (24) and MIF may be the same 
substance. Therefore, the effect of MIF in the capillary test was correlated with 
its  effect on  the  electrophoretic  mobility  of macrophages.  100  #l  of 100-fold 
concentrated supernates showed 45% migration inhibition and the same concen- BLOCK,  JAKSCHE,  BAMBERGER,  AND  RUHENSTROTH-BAUER 
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Fro.  7.  Dose-response relationship of MIF protein in the capillary test.  Concentrations 
used are calculated per ml MEM medium and used per chamber. Each point represents 
the average of six assays. The vertical bars represent standard deviation. 
tration, and the same material resulted in 15±8.5% (8 measurements) reduction 
of the electrophoretic mobility of macrophages.  As indicated above,  MIF-rich 
material  (appropriate  fractions  after gel filtration)  inhibited the migration  of 
macrophages  ---40±9.6%  (7  determinations).  The  electrophoretic  mobility  of 
macrophages  in  the  presence  of  this  MIF-rich  fraction  was  17.5±6.2%  (6 
measurements)  lower  than  that  of cells  treated  with  control  material.  The 
migration  inhibition  activity of B3 was 80±8.5%  (6 determinations).  Fraction 
B3 at the same concentration  decreased the electrophoretic mobility of macro- 
phages as well, to ---24.5±6.3% (5 experiments), whereas other fractions had no 
effect. Since biological activity of the MIF and the MSF may be identical,  the 
dose-response relationship  of B3 was studied for both tests.  For the migration 
inhibition  test  the  amount  of protein  was  varied  from  0.25-2.5  /~g  in  1  ml 
MEM. For the cell electrophoresis measurements, the same amounts of protein 
were diluted with 2 ml Medium TC 199. Figs. 7 and 8 show the effect of protein 
B3 in both tests.  While  in the capillary test,  a  protein concentration  of 2-2.5 
~g/ml  caused  77.4±5.4%  inhibition  (6  determinations),  the  same  amount  of 
protein  in  2  ml  of Medium  TC  199  lowered  the  electrophoretic  mobility  of 
macrophages to a  maximum of 27.8±6.3% (5 measurements). 
Effect  of Neutralization  by  Anti-MIF Antibodies.  50  ftl  of  lymphocyte 
supernates causing migration  inhibition of ----35-40% and 50 ~1 of MIF protein 
which inhibited the migration by ~75% were incubated with different dilutions 
of anti-MIF antibodies for 1 h  at 37°C.  Then the solutions were centrifuged at 
10,000  g  for  10  min  and  the  supernates  were  used  for the  capillary  test.  In 
using antibody dilutions of 1:1 and  1:2, the inhibition  effect of the lymphocyte 
supernate  and  the  purified  MIF  was  neutralized  (95-100%  migration).  After 
treatment with 1:3 diluted antibodies, the supernate affected migration inhibi- 
tion by -~20%, and the purified MIF by ---35% (5 experiments).  The electropho- 
retic mobility of macrophages was lowered by using the same concentrations of 
supernates  to  ---10%, and of purified MIF protein to  ----25% (6 measurements). 
This effect of the supernates on electrophoretic mobility was fully neutralized by 
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FIG.  8.  Effect of different concentrations of purified MIF on the electrophoretic mobility 
(EM) of macrophages. The cells at a  concentration of 107 were incubated in 2 ml of medium 
TC 199 at 23°C before measurements were taken. Each point represents the average of five 
measurements. The vertical bars represent standard deviation. 
electrophoretic  mobility  of the  purified  MIF  protein  was  neutralized  when 
antibody  dilutions  1:1  and  h2  were  used  (4  measurements).  In  using  an 
antibody  dilution  of  1:3, the  electrophoretic  mobility  of  macrophages  was 
lowered to ~10%  (4 experiments). 
Discussion 
As mentioned by Taylor (25) the preparation of MIF from Con A-stimulated 
lymphocytes appears  to be rather  inefficient.  Conventional  methods  such  as 
Sephadex  chromatography  and  disc  electrophoresis  on  polyacrylamide  gels 
were not successful in  purifying preparative  amounts  of MIF.  Therefore,  we 
attempted the purification by using preparative isotachophoresis which allows 
fractionation  of proteins  on  the  basis  of charge  and  molecular  weight.  The 
application of preparative  isotachophoresis resulted in the successful purifica- 
tion of a protein with MIF-like activity obtained from Con A-activated lympho- 
cyte supernates.  The degree of purification of human  MIF was 400-fold, if the 
capillary test can be considered as a criterion for the estimation of specific MIF 
activity. The recovery of specific MIF activity after purification of Sephadex G- 
100  was  ~20%,  in  agreement  with  the  observations  of Remold  et  al,  (5). 
Calculation  of the  recovery  at  various  stages  during  purification  was  not 
possible in the absence of a  reliable quantitative  radioimmunoassay.  Fraction 
B3 contained MIF, and this was concluded from the observation that migration 
inhibitory activity of ----75-85% was detected only in this fraction with a specific 
dose-response  relationship.  The  purified  protein  appeared  to  be  relatively 
homogeneous  on  10%  acrylamide  gel  with  a  mol  wt of ~2.5×104  daltons,  as 
estimated  by  SDS  gel  electrophoresis  and  Sephadex  G-100  chromatography. 
This  finding  is  in  agreement  with  Taylor et  al.  (25),  Rocklin et al.  (6),  and 
Preece and Light  (23),  who detected MIF activity in partially purified super- 
nates of activated lymphocytes in  a  similar  region of the chromatogram.  On 
SDS  gels,  B3  seems to  be  composed of two  proteins;  one  with  a  mol  wt of 
--25,000 daltons, and a small band with a mol wt of 34,000 daltons. In addition, 
fraction B3 is contaminated with low amounts of protein A, which is also found BLOCK,  JAKSCHE,  BAMBERGER,  AND  RUHENSTROTH-BAUER  551 
as a major component in control supernates. Isoelectric focusing of fraction B3 
resulted in two bands  in the region of (pI)  3.5-4,  which leads to the further 
possibility of microheterogeneity of MIF apart from the possibility of contami- 
nation and/or multiple subunits. As indicated earlier, the lymphocytes used for 
MIF production were purified on  a  Ficoll-Hypaque gradient.  Despite careful 
washing of the cells, it seems likely that the supernates were still contaminated 
by serum proteins or hemoproteins, as mentioned by Bendtzen (8), and Geczy 
et al.  (9). The existence of a  protein in lymphocyte supernates in the mol wt 
range of ---68,000 daltons was observed in both studies. 
Isolation  of specific  antibodies  was  performed by  initial  preparation  of a 
mixed population of antibodies against fractions B and removal of nonspecific 
antibodies  by  its  selective absorption  with  proteins  of control material.  Al- 
though the titer of the antiserum was low, it was efficient enough to neutralize 
MIF activity in the capillary test and in the cell electrophoresis apparatus. 
Our  studies  show  that  MIF  is  a  relatively  heat-stable  protein  since  its 
incubation for 30 min at 56°C resulted in loss of no biological activity, although 
boiling for 20 min destroyed its activity completely (unpublished data). This is 
in  agreement  with  earlier  findings  of Rocklin  et  al.  (6). Our  studies  with 
purified  MIF  show  its  biological  effect is  caused by  very small  amounts  of 
protein,  as predicted by Sorg and Bloom (26) and Remold et al.  (5). However, 
the relatively small yield of MIF (250 ftg from Con A-stimulated lymphocytes, 
prepared from 80 liters of fresh human blood) could be the result of a  loss of 
material during preparative procedures such as dialysis,  and/or the result of 
heterogeneous origin of the human blood samples. 
It was speculated by Preece and Light (23) and Field et al.  (11) that the MSF 
produced from sensitized lymphocytes after incubation with the EF  (24),  and 
MIF  may be the same substance.  The dose-response relationship of purified 
MIF protein studied in the cell electrophoresis apparatus correlated very well 
with the previously reported dose-response relationship for MSF,  studied by 
Carnegie et al.  (27). A  highly purified MSF preparation was  detected in the 
same range of molecular weight where MIF activity was found (23). The cause 
for the slowing effect appears to be a  change in the surface charge (24). Since 
MIF protein can cause the same effect in a  comparable dose, it is likely that 
MIF is identical to MSF. Remold (28) found that during the early steps of MIF 
action,  MIF  appears  to bind to  the surface membrane of macrophages.  This 
may indicate that MIF interacts with membrane receptors, which could change 
the surface charge of macrophages. Therefore, we suggest that the first step of 
MIF action could be a change in the surface charge of macrophages. 
The  availability  of specific  antibodies  against  human  MIF  will  provide  a 
possible  tool for further studies on  MIF  and its  mode of action.  By using  a 
senitive radioimmunoassay (studies in progress),  precise quantitation can be 
achieved which should allow studies of its role in disease. 
Summary 
Using gel filtration and preparative isotachophoresis, the migration inhibi- 
tory factor (MIF) was highly purified from human lymphocytes activated with 
concanavalin A.  MIF is an acidic protein with a  mol wt of ----25,000 daltons as 552  CHARACTERIZATION  OF  HUMAN  MIGRATION  INHIBITORY  FACTOR 
determined by gel filtration and analytical polyacrylamide gel electrophoresis 
in  the  presence of sodium  dodecyl sulfate.  The protein  inhibits  migration  of 
macrophages in the capillary test and in addition,  has a  slowing effect on the 
electrophoretic mobility of guinea pig peritoneal macrophages. Rabbit antibod- 
ies  specific  for  this  protein,  as  determined  by  immunochemical  techniques, 
neutralized the biological effect of MIF on migration and on the electrophoretic 
mobility of macrophages. 
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